ISSN: 2375-3838
International Journal of Clinical Medicine Research  
Manuscript Information
 
 
Evaluation of Modifiable Risk Factors for Stroke in Bangladesh: A Tertiary Level Hospital Experience
International Journal of Clinical Medicine Research
Vol.1 , No. 4, Publication Date: Oct. 8, 2014, Page: 140-145
1645 Views Since October 8, 2014, 616 Downloads Since Apr. 14, 2015
 
 
Authors
 
[1]    

Aminur Rahman, Fellow of Interventional Neuroradiology, Department of Neuroradiology, University Hospital of Zurich 8091, Switzerland.

[2]    

Hasan Emre Aydin, Eskisehir State Hospital, Department of Neurosurgery, Eskisehir26100, Turkey.

[3]    

Surasak Komonchan, Department of Neurology, Prasat Neurological Institute, Bangkok10400, Thailand.

[4]    

Uttam Kumar Saha, Department of Neurology, National Institute of Neurosciences& Hospital, Dhaka 1207, Bangladesh.

[5]    

Firoz Ahmed Quraishi, Department of Interventional Neurology, National Institute of Neurosciences& Hospital, Dhaka1207, Bangladesh.

[6]    

Sakhawat Hossain, Department of Neurology, Sir Salimullah Medical College, Dhaka1100, Bangladesh.

 
Abstract
 

Background: there is limited study describing such stroke in tertiary level hospital experiences from developing countries like Bangladesh Objectives: The aim study is to evaluate the modifiable risk factors stroke in both young and old age group. Methods: A retrospective audit of medical records of all patients presenting between July 2011 to November 2012 with a stroke was conducted. Information about clinical presentation, modifiable risk factors laboratory and radiological investigations was collected. Data was entered and analyzed using SPSS14.0. Results: O f total 183 cases 31 were young adults and 152 old patients between 18 to 100 years. Mean age young adult was 38.76 (± 6.379) and old age was 64.06 (± 11.238). 65.02% were male & 34.97% were female and the ratio was 1.9:1. Among patients majority had the Ischemic stroke in both age groups. In young age group 18 patients were diagnosed with ischemic stroke (58.06%) while 13 patients presented with hemorrhagic stroke (41.94%). In old age group 103 patients were diagnosed with ischemic stroke (67.76%) while 49 patients presented with hemorrhagic stroke (32.24%). Hypertension was the most common modifiable risk factor seen in both in the young (54.8.0%) and in old age group (55.9%), followed by previous history of transient ischemic attack (19.4%) and oral contraceptive pills (16.1%) in young age group and dyslipidaemia (23.7%), previous history of transient ischemic attack (20.4) and diabetes mellitus (DM) (19.7%) in old age group. Conclusion: A high prevalence of modifiable risk factors such as hypertension in both groups in stroke patients was observed in the tertiary level hospital in Bangladesh.


Keywords
 

Risk Factors, Stroke, Hypertension, Transient ischemic Attack, Oral Contraceptive Pills, Dyslipidaemia, Diabetes Mellitus


Reference
 
[01]    

World Health Organization Cerebrovascular disorders: a clinical and research classification.43. Geneva, World Health Organization; 1978

[02]    

Feigin VL. Stroke in developing countries: can the epidemic be stopped and outcomes improved? Lancet Neurol. [Reflection and Reaction]. 2007 Feb; 6(2):94-7.

[03]    

Safeer M, Tariq M, Rahman U. Frequency of risk cases in Naseer Teaching Hospital, Peshawar, Pakistan. Pak factors of cerebral infarction in stroke patients. A study of 100 J Med Sci, 2008; 24. 1: 109-13.

[04]    

Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971 Oct; 49(4):509-38.

[05]    

Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009 Apr; 8(4):355-69.

[06]    

Truelsen T, Heuschmann P, Bonita R, Arjundas G, Dalal P, Damasceno A, et al. Standard method for developing stroke registers in low-income and middle-income countries: experiences from a feasibility study of a stepwise approach to stroke surveillance (STEPS Stroke). Lancet Neurol. 2007 Feb; 6 (2):134-9.

[07]    

Moussouttas M, Aguilar L, Fuentes K, Anyanwu B, Manassarians H, Papamitsakis N, et al. Cerebrovascular disease among patients from the Indian subcontinent. Neurology. 2006 Sep 12; 67(5):894-6.

[08]    

Feigin VL LC, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. [Review]. 2003 Jan;2(1):43-53.

[09]    

Sacco RL, Benjamin EJ, Broderick JP, Dyken Mark, Easton JD, Feinberg WM.1997, ‘Risk factors’. Stroke, vol.28: 1507-17.

[10]    

Lin Y, Li YS, Xu Q, Shi GW, Li HW, Geng JL. [The impact of stroke clinic on improving the compliance with the guidelines for secondary prevention of ischemic stroke]. Zhonghua Nei Ke Za Zhi. 2007 Sep;46(9):736-9.

[11]    

Mouradian MS, Hussain MS, Lari H, Salam A, Senthilselvan A, Dean N, et al. The impact of a stroke prevention clinic in diagnosing modifiable risk factors for stroke. Can J Neurol Sci. 2005 Nov;32(4):496-500.

[12]    

Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke. 1988 Dec;19(12):1497-500.

[13]    

Brott T, Adams HP, Jr., Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989 Jul; 20(7):864-70.

[14]    

Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957 May; 2(5):200-15.

[15]    

Wade DT, Collin C. The Barthel ADL Index: a standard measure of physical disability? Int Disabil Stud. 1988; 10(2):64-7.

[16]    

Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993 Jan; 24(1):35-41.

[17]    

Diagnosis and classification of diabetes mellitus. American Diabetes Association. Diabetes Care. 2006 Jan; 29 Suppl 1: S43-8.

[18]    

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 21; 289(19):2560-72.

[19]    

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001 May 16; 285(19):2486-97.

[20]    

Brown MM, Rudd A, McGovern R. Transient ischemic attack-- proposed new definition. N Engl J Med. 2003 Apr 17; 348(16): 1607-9; author reply -9.

[21]    

Abbott RD, Yin Y, Reed DM, Yano K. Risk of stroke in male cigarette smokers. N Engl J Med. 1986 Sep 18; 315(12):717-20.

[22]    

Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991, Aug; 22(8):983-8

[23]    

Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Gender Differences in Stroke Incidence and Post stroke Disability in the Framingham Heart Study. Stroke. 2009 Apr; 40 (4)1032-7.

[24]    

Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009 Apr; 40(4): 1082-90.

[25]    

Lindsay KW, Bone I, Callander R. Neurology and Neurosurgery illustrated. 4th ed. Edinburgh: Churchill Livingstone; 2004:238-97.

[26]    

Shinton R, Beevers G; Meta-analysis of relation between cigarette smoking and stroke. BMJ, 1989; 298:789-94.

[27]    

Howard G, Evans GW, JR Crouse 3rd, JF Toole, JE Ryu, C Tegeler, J Frye-Pierson, E Mitchell and L Sanders. A prospective reevaluation of transient ischemic attacks as a risk factor for death and fatal or nonfatal cardiovascular events; Stroke, 1994; 25:342-5.

[28]    

Jacobs DR, Jr., McGovern PG, Blackburn H. The US decline in stroke mortality: what does ecological analysis tell us? Am J Public Health. 1992 Dec; 82(12):1596-9.

[29]    

Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991, Aug; 22(8):983-8

[30]    

Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994, 16; 271(11):840-4.

[31]    

Burchfield CM, Curb JD, Rodriguez BL, Abbott RD, Chiu D, Yano K. Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program. Stroke. 1994; 25(5):951-7.

[32]    

Petitti DB, Sidney S, Bernstein A, et al. Stroke in Users of Low-Dose Oral Contraceptives. NEJM, 1996; 335:8-15.

[33]    

Sarker T K, Kuddus M R, Khan M R K, Anwar Ullah AKM, Islam M R, Haque A; Dyslipidaemia in Cortical Versus Subcortical Infarction. Bangladesh Journal of Neuroscience. 2008, 24; 1:24-33.





 
  Join Us
 
  Join as Reviewer
 
  Join Editorial Board
 
share:
 
 
Submission
 
 
Membership